Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tissue selective compounds in the treatment of ovarian cancer

Tissue selective compounds in the treatment of ovarian cancer

US Patent 6232307 · Granted May 15, 2001

Estimated economic value: $281,573,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Estrogen receptor-modulating compounds2025
Systems and methods for extracting and isolating purified wheat embryo products2025
Estrogen receptor-modulating compounds2025
AR+breast cancer treatment methods2025
Estrogen receptor-modulating compounds2024
AR+ breast cancer treatment methods2023
Heterocyclic compounds as BET inhibitors2023
Estrogen receptor-modulating compounds2022
Selective androgen receptor modulators2018
Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type 2017
Selective androgen receptor modulators2015
Selective androgen receptor modulators2015